Dedicated to Innovation in Glaucoma
Innovation at ZEISS is an ongoing process. We know that early disease detection and disease progression management are important for you and your patients. Journey with us today through the various technologies we have discovered and made better because of your contribution to the field of glaucoma management.
Paul Singh, MD
The Eye Centers of Racine and Kenosha, Wisconsin, USA
Ryo Asaoka, MD, PhD
Seirei Hamamatsu General Hospital, Seirei Christopher University, The Graduate School for the Creation of New Photonics Industries, Japan.
Matteo Sacchi, MD
Head of Glaucoma Center Ospedale San Giuseppe, Milan, Italy
Guz Gazzard, MD, MA, MBBChir
Consultant Ophthalmic Surgeon and Chief Investigator, LiGHT Trial, Director of Surgery, Moorfields Eye Hospital, Professor of Ophthalmology, Glaucoma Studies, UCL London, UK
Gloria Roberti, MD, PhD
Advances in Standard Automated Perimetry
Glaucoma Research Unit IRCCS Fondazione G.B. Bietti, Ospedale Britannico, Rome, Italy
Frank Deubel, PhD
Impact of Intraoperative OCT in Glaucoma Surgery
ZEISS, Oberkochen, Germany
Francesco Oddone, MD, PhD
SLT Choice For Patients With Open Angle Glaucoma
Glaucoma Research Unit, Head of the Glaucoma Unit, IRCCS Fondazione G.B.Bietti, Rome, Italy
Sofia Porto Castro, MD
Optimizing OCT Usage in Glaucoma Management
Instituto Gómez-Ulla, Santiago de Compostela, Spain
Journey of innovation in glaucoma
Explore the interactive timeline and see how have the ZEISS technologies evolved over the years and have changed the way glaucoma is managed.
ZEISS launches the first OCT for use in ophthalmic clinics.
SITA algorithm was published to empower exclusively HFA perimetry.
Gold standard ONH assessment was pioneered by Stratus.
Guided Progression Analysis (GPA™) leaped the doctors’ ability to differentiate true change from random variability.
3-D SmartCube introduced dynamic data through ZEISS CIRRUS.
The industry’s first groundbreaking integration of OCT and visual field diagnostic analysis launched exclusively with FORUM® from ZEISS.
Comprehensive anterior assessment functionality was added to CIRRUS OCT.
Humphrey® Field Analyzer 3 (HFA3) becomes the first perimeter to introduce patented Liquid Lens technology for refractive correction.
SITA Faster enabled the most efficient threshold visual field test in gold standard perimetry.
SITA™ Faster 2x less 24-2 test time without any clinically significant difference vs the benchmark; a new 24-2C test adds macula points.
Microvasculature dynamic analysis comes from PLEX Elite to CIRRUS.
Microcapillary visualization through Swept Source research with PLEX Elite 9000 enthuses applications of microvasculature dynamic analysis with CIRRUS AngioMetrix in glaucoma clinics. Courtesy of Prof. C. Leung, Hong Kong University
ZEISS SLT on VISULAS green therapeutic laser platform
An evolution of Selective Laser Trabeculoplasty (SLT)